HPV Masterclass Banner

Register for webinar

Terms of Participation: By continuing, you agree that your virtual presence is your willingness to participate in this virtual event. This virtual event will be recorded by MSD for audit and quality purposes. Your image including other identifiable information may get recorded by MSD or its third-party vendors/service providers during this virtual event. If you wish you may turnoff the camera and micro phone of your device.

If Already Registered? Click here

New Users Click here

Event Agenda 17th June 2025

Time Session Speaker
5:15 PM - 5:30 PM Introduction Dr. Priya Ganeshkumar
5:30 PM - 5:55 PM Topic 1: Journey Towards Cervical CancerElimination – How and By When- WHO Strategy Dr. Saritha Shamsunder
5:55 PM - 6:20 PM Topic 2: Cervical cancer elimination: Role of gender neutral vaccination Dr. Priya Ganeshkumar
6:20 PM - 6:30 PM Quiz Dr. Ashutosh Kakade (Moderator) MSD Team

Speaker

HPV MASTERCLASS

Date: Tuesday, 17th June, 2025
Time: 5:15 PM to 6:30 PM Indian Standard Time
Duration: 1 Hour 15 minutes

This online meeting is being hosted by Bioquest on behalf of MSD Pharmaceuticals Pvt. Ltd. (MSD) on WeBQlive platform.
The information shared is intended solely for healthcare professionals for scientific exchange. The session may include discussions on MSD products in accordance with applicable laws. Any product names, brands, logos used in this session remain the property of their respective owners.

MSD Logo

Copyright © 2025 MSD Pharmaceuticals Pvt. Ltd.
Registered Office: Platina, 10th Floor, Plot No. C-59, G Block, Bandra-Kurla Complex, Bandra East, Mumbai 400051, India.

AE Reporting

To report Adverse Events (AEs) related to our products, please contact:

Mode of reporting the adverse event Details
PV Dedicated Fax 91-124-4647339
PV Toll Free Number 18001032642
E-mail dpoc_india@merck.com
Postal Address International Pharmacovigilance Department,
MSD Pharmaceuticals Pvt. Ltd., 6th Floor, Vatika Towers-B,
Sector-54, Gurgaon 122002

Adverse Event (AE): Per the International Conference on Harmonization (ICH), an adverse event (AE) is defined as any untoward medical occurrence in a patient or clinical investigation subject administered a pharmaceutical product and which does not necessarily have to have a causal relationship with this treatment. An AE can therefore be any unfavorable and unintended sign (including an abnormal laboratory finding, for example), symptom, or disease temporally associated with the use of a medicinal product, whether or not considered related to this product.

Privacy Note:Any personal data provided by you will be treated by MSD with full respect of your privacy. Please read more about MSD's privacy commitment at https://www.msdprivacy.com/in/en. In case you want to delete or edit Personal Health Information (PHI) already collected by MSD India, please request at MSDPharmacovigilance.india@merck.com or call +91-124-4647339.

International Pharmaceuticals, MSD Pharmaceuticals Pvt. Ltd.